Amy Schumer is coming clean about her weight loss drug journey. In an Instagram post she shared on March 21, she revealed she ...
Carlsbad’s Ionis Pharmaceuticals struck a deal worth up to $940 million with Japan-based Ono Pharmaceutical for its medicine ...
Schumer said she was having success on Mounjaro after previously being unable to "handle" Ozempic's side effects.
The 76-year-old Oscar winner got serious about her health following her diagnosis for type 2 diabetes in 2017, but there was ...
The 62-year-old comic and actress, who suffers from diabetes, made the admission while updating fans on her recent move to Ireland - in protest at the Donald Trump administration - and the significant ...
Amy Schumer recently took to her Instagram handle to share her experience with Midi Health. The 43-year-old actress-comedian ...
In a video shared on her Instagram, the comedian told fans that her intent is to always "keep it a hundred." Before diving in ...
Weight loss clinics, telehealth companies, physicians, and pharmacies that have been prescribing or dispensing compounded GLP ...
With Eli Lilly’s Mounjaro entering India, the weight-loss drug race is on. But with steep prices and generics on the way, how ...
The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...
Amy Schumer’s experience with Mounjaro has been vastly different from when she tried an alternative weight-loss medication ...
Eli Lilly’s Mounjaro targets India’s $150 billion weight-loss market amid rising diabetes crisis
Eli Lilly launches Mounjaro in India, targeting the $150B weight-loss market. The GLP-1 drug offers diabetes control & major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results